Zhihu (ZH) Competitors

Astrana Health (NASDAQ:ASTH) and Zhihu (NYSE:ZH) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

Is ASTH or ZH more profitable?

Astrana Health has a net margin of 1.04% compared to Zhihu's net margin of -0.52%. Astrana Health's return on equity of 3.43% beat Zhihu's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.04%	3.43%	1.87%
Zhihu	-0.52%	-0.41%	-0.30%

Do analysts rate ASTH or ZH?

Astrana Health currently has a consensus price target of $53.29, suggesting a potential upside of 73.68%. Zhihu has a consensus price target of $4.70, suggesting a potential downside of 1.57%. Given Astrana Health's higher probable upside, analysts plainly believe Astrana Health is more favorable than Zhihu.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Zhihu	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to ASTH or ZH?

In the previous week, Astrana Health had 1 more articles in the media than Zhihu. MarketBeat recorded 4 mentions for Astrana Health and 3 mentions for Zhihu. Astrana Health's average media sentiment score of 1.04 beat Zhihu's score of 0.86 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zhihu	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings & valuation, ASTH or ZH?

Astrana Health has higher revenue and earnings than Zhihu. Zhihu is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$2.03B	0.85	$43.15M	$0.51	60.16
Zhihu	$493.05M	0.85	-$23.54M	-$0.02	-238.75

Which has more risk & volatility, ASTH or ZH?

Astrana Health has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Zhihu has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in ASTH or ZH?

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 28.9% of Zhihu shares are held by institutional investors. 20.0% of Astrana Health shares are held by insiders. Comparatively, 13.6% of Zhihu shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Astrana Health beats Zhihu on 14 of the 16 factors compared between the two stocks.